联环药业(600513.SH)子公司艾司唑仑片通过一致性评价

Core Viewpoint - The announcement indicates that Lianhuan Pharmaceutical's subsidiary, Changle Pharmaceutical, has received approval from the National Medical Products Administration for the supplemental application of Estazolam tablets, confirming the drug's consistency in quality and efficacy as a generic medication [1] Group 1: Company Information - Lianhuan Pharmaceutical's subsidiary, Changle Pharmaceutical, has been granted approval for Estazolam tablets, which are primarily used for treating anxiety and insomnia [1] - Estazolam is classified as a benzodiazepine sedative-hypnotic drug, commonly used in clinical settings [1] Group 2: Industry Context - The approval of Estazolam tablets aligns with the ongoing trend of generic drugs achieving consistency in quality and efficacy, which is crucial for market competitiveness [1]